Corticosteroid Protection Against COVID-19: Begin with the Nose.
作者信息
Lipworth Brian J, Chan Rory, Carr Tara
机构信息
Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, UK.
Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, UK.
出版信息
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3941-3943. doi: 10.1016/j.jaip.2021.08.025. Epub 2021 Sep 17.
Abstract
摘要
相似文献
1
Corticosteroid Protection Against COVID-19: Begin with the Nose.
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3941-3943. doi: 10.1016/j.jaip.2021.08.025. Epub 2021 Sep 17.
2
Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e270-e271. doi: 10.3928/19382359-20210701-01. Epub 2021 Jul 1.
3
Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe COVID-19?
Eur Respir J. 2022 Oct 20;60(4). doi: 10.1183/13993003.01220-2022. Print 2022 Oct.
4
Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e271. doi: 10.3928/19382359-20210520-01. Epub 2021 Jul 1.
5
Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.
J Clin Pharmacol. 2021 Sep;61(9):1145-1148. doi: 10.1002/jcph.1929. Epub 2021 Jul 10.
6
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients.
mSystems. 2023 Dec 21;8(6):e0072623. doi: 10.1128/msystems.00726-23. Epub 2023 Oct 24.
7
The impact of inhaled corticosteroid on SARS-CoV2 infection.
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2939-2940. doi: 10.1016/j.jaip.2021.04.039.
8
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study.
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.001. Epub 2020 Nov 8.
9
Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
Intensive Care Med. 2021 Mar;47(3):355-356. doi: 10.1007/s00134-020-06330-w. Epub 2021 Jan 2.
10
Corticosteroids in COVID-19: one size does not fit all.
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00224-2021. Print 2021 Apr.
引用本文的文献
1
Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID-19.
Laryngoscope. 2025 Feb;135(2):517-528. doi: 10.1002/lary.31761. Epub 2024 Sep 13.
2
Different effects of vaccine on VST in critical and non-critical COVID-19 patients: A retrospective study of 363 cases.
Heliyon. 2023 May;9(5):e16017. doi: 10.1016/j.heliyon.2023.e16017. Epub 2023 May 1.
3
Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study.
Cureus. 2022 Jul 23;14(7):e27182. doi: 10.7759/cureus.27182. eCollection 2022 Jul.
4
Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter".
J Allergy Clin Immunol Pract. 2022 Jan;10(1):355-356. doi: 10.1016/j.jaip.2021.10.062.
Zotero 插件